1. RipollC, GroszmannR, Garcia‐TsaoG, et al.Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology2007;133:481. CrossRef

2. DooleyJ, SherlockS. Sherlock's Diseases of the Liver and Biliary System. 12th ed. Chichester, West Sussex; Hoboken, NJ: Wiley Blackwell; 2011:xvi. CrossRef

3. FlochMH, NetterFH. Netter's Gastroenterology. 2nd ed. Philadelphia: Saunders/Elsevier; 2010:xii.

4. MaruyamaHS, ArunJ. Portal hypertension: nonsurgical and surgical management. In: SchiffER, MaddreyWC, SorrellMF(eds). Schiff's Diseases of the Liver. 11th ed. West Sussex, UK: John Wiley & Sons; 2012:326.

5. GroszmannRJ, Garcia‐TsaoG, BoschJ, et al.Beta‐blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med2005;353:2254. CrossRef

6. D'AmicoG, Garcia‐PaganJC, LucaA, BoschJ. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology2006;131:1611. CrossRef

7. AvgerinosA, ArmonisA, StefanidisG, et al.Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology2004;39:1623. CrossRef

8. Garcia‐TsaoG, SanyalAJ, GraceND, et al.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology2007;46:922. CrossRef

9. Garcia‐TsaoG. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology2001;120:726. CrossRef

10. BhathalPS, GrossmanHJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol1985;1:325. CrossRef

11. BlendisLM, OrregoH, CrossleyIR, et al.The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Hepatology1982;2:539. CrossRef

12. GrossmanHJ, GrossmanVL, BhathalPS. The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation. Hepatology1998;27:446. CrossRef

13. IwakiriY. Endothelial dysfunction in the regulation of cirrhosis and portal hypertension. Liver Int2012;32:199. CrossRef

14. PerriRE, LangerDA, ChatterjeeS, et al.Defects in cGMP‐PKG pathway contribute to impaired NO‐dependent responses in hepatic stellate cells upon activation. Am J Physiol Gastrointest Liver Physiol2006;290:G535. CrossRef

15. GrauperaM, MarchS, EngelP, et al.Sinusoidal endothelial COX‐1‐derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am J Physiol Gastrointest Liver Physiol2005;288:G763. CrossRef

16. BatallerR, GinèsP, NicolásJM, et al.Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology2000;118:1149. CrossRef

17. HerathCB, LubelJS, JiaZ, et al.Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. Am J Physiol Gastrointest Liver Physiol2009;297:G98. CrossRef

18. IwakiriY, GroszmannRJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol2007;46:927. CrossRef

19. MerkelSM, KamounW, KaraaA, et al.LPS inhibits endothelin‐1‐mediated eNOS translocation to the cell membrane in sinusoidal endothelial cells. Microcirculation2005;12:433. CrossRef

20. KamounWS, KaraaA, KresgeN, et al.LPS inhibits endothelin‐1‐induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin‐1. Hepatology2006;43:182. CrossRef

21. JagaveluK, RoutrayC, ShergillU, et al.Endothelial cell toll‐like receptor 4 regulates fibrosis‐associated angiogenesis in the liver. Hepatology2010;52:590. CrossRef

22. ThabutD, ShahV. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?J Hepatol2010;53:976. CrossRef

23. BattagliaS, AngusP, Chin‐DustingJP. Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol2006;21:1189. CrossRef

24. AlbornozL, MottaA, AlvarezD, et al.Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances. J Hepatol2001;35:452. CrossRef

25. IwakiriY, GroszmannRJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology2006;43(2 Suppl 1):S121. CrossRef

26. HennenbergM, TrebickaJ, SauerbruchT, HellerJ. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut2008;57:1300. CrossRef

27. SikulerE, GroszmannRJ. Interaction of flow and resistance in maintenance of portal hypertension in a rat model. Am J Physiol1986;250:G205.

28. FernandezM, VizzuttiF, Garcia‐PaganJC, et al.Anti‐VEGF receptor‐2 monoclonal antibody prevents portal‐systemic collateral vessel formation in portal hypertensive mice. Gastroenterology2004;126:886. CrossRef

29. LinHC, SoubraneO, CailmailS, LebrecD. Early chronic administration of propranolol reduces the severity of portal hypertension and portal‐systemic shunts in conscious portal vein stenosed rats. J Hepatol1991;13:213. CrossRef

30. SarinSK, GroszmannRJ, MoscaPG, et al.Propranolol ameliorates the development of portal‐systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest1991;87:1032. CrossRef

31. Garcia‐TsaoG, GraceND, GroszmannRJ, et al.Short‐term effects of propranolol on portal venous pressure. Hepatology1986;6:101. CrossRef

32. Garcia‐PaganJC, FeuF, NavasaM, et al.Long‐term haemodynamic effects of isosorbide 5‐mononitrate in patients with cirrhosis and portal hypertension. J Hepatol1990;11:189. CrossRef

33. NavasaM, ChestaJ, BoschJ, RodésJ. Reduction of portal pressure by isosorbide‐5‐mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. Gastroenterology1989;96:1110.

34. Garcia‐PaganJC, FeuF, BoschJ, RodesJ. Propranolol compared with propranolol plus isosorbide‐5‐mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med1991;114:869. CrossRef

35. VorobioffJ, PicabeaE, GamenM, et al.Propranolol compared with propranolol plus isosorbide dinitrate in portal‐hypertensive patients: long‐term hemodynamic and renal effects. Hepatology1993;18:477. CrossRef

36. SalmeronJM, Ruiz del ArbolL, GinèsA, et al.Renal effects of acute isosorbide‐5‐mononitrate administration in cirrhosis. Hepatology1993;17:800.

37. LinHC, YangYY, HouMC, et al.Acute administration of carvedilol is more effective than propranolol plus isosorbide‐5‐mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am J Gastroenterol2004;99:1953. CrossRef

38. DeBK, DasD, SenS, et al.Acute and 7‐day portal pressure response to carvedilol and propranolol in cirrhotics. J Gastroenterol Hepatol2002;17:183. CrossRef

39. BanaresR, MoitinhoE, PiquerasB, et al.Carvedilol, a new nonselective beta‐blocker with intrinsic anti‐alpha1‐adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology1999;30:79. CrossRef

40. BanaresR, MoitinhoE, MatillaA, et al.Randomized comparison of long‐term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology2002;36:1367. CrossRef

41. TripathiD, FergusonJW, KocharN, et al.Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology2009;50:825. CrossRef

42. AbraldesJG, Rodríguez‐VilarruplaA, GrauperaM, et al.Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol2007;46:1040. CrossRef

43. TrebickaJ, HennenbergM, LalemanW, et al.Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho‐kinase and activation of endothelial nitric oxide synthase. Hepatology2007;46:242. CrossRef

44. AbraldesJG, AlbillosA, BañaresR, et al.Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology2009;136:1651. CrossRef

45. ZafraC, AbraldesJG, TurnesJ, et al.Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology2004;126:749. CrossRef

46. MarroneG, RussoL, RosadoE, et al.The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial‐stellate cell deactivation induced by statins. J Hepatol2013;58:98. CrossRef

47. ToxU, SteffenHM. Impact of inhibitors of the renin‐angiotensin‐aldosterone system on liver fibrosis and portal hypertension. Curr Med Chem2006;13:3649. CrossRef

48. TandonP, AbraldesJG, BerzigottiA, et al.Renin‐angiotensin‐aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta‐analysis. J Hepatol2010;53:273. CrossRef

49. ViannaA, HayesPC, MoscosoG. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology1987;93:876.

50. TajiriT, YoshidaH, ObaraK, et al.General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc2010;22:1. CrossRef

51. SarinSK, LahotiD, SaxenaSP, et al.Prevalence, classification and natural history of gastric varices: a long‐term follow‐up study in 568 portal hypertension patients. Hepatology1992;16:1343. CrossRef

52. KovalakM, LakeJ, MattekN, et al.Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc2007;65:82. CrossRef

53. MerliM, NicoliniG, AngeloniS, et al.Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol2003;38:266. CrossRef

54. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med1988;319:983. CrossRef

55. BeppuK, InokuchiK, KoyanagiN, et al.Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc1981;27:213. CrossRef

56. VillanuevaC, PiquerasM, AracilC, et al.A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol2006;45:560. CrossRef

57. CarbonellN, PauwelsA, SerfatyL, et al.Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology2004;40:652. CrossRef

58. ChalasaniN, KahiC, FrancoisF, et al.Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol2003;98:653. CrossRef

59. BoschJ, Garcia‐PaganJC. Prevention of variceal rebleeding. Lancet2003;361:952. CrossRef

60. KimT, ShijoH, KokawaH, et al.Risk factors for hemorrhage from gastric fundal varices. Hepatology1997;25:307. CrossRef

61. TripathiD, TherapondosG, JacksonE, et al.The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut2002;51:270. CrossRef

62. BariK, Garcia‐TsaoG. Treatment of portal hypertension. World J Gastroenterol2012;18:1166. CrossRef

63. EisenGM, EliakimR, ZamanA, et al.The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three‐center pilot study. Endoscopy2006;38:31. CrossRef

64. LapalusMG, DumortierJ, FumexF, et al.Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy2006;38:36. CrossRef

65. LuY, GaoR, LiaoZ, et al.Meta‐analysis of capsule endoscopy in patients diagnosed or suspected with esophageal varices. World J Gastroenterol2009;15:1254. CrossRef

66. ChavalitdhamrongD, JensenDM, SinghB, et al.Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clin Gastroenterol Hepatol2012;10:254. CrossRef

67. StiphoS, TharalsonE, HakimS, et al.String capsule endoscopy for screening and surveillance of esophageal varices in patients with cirrhosis. J Interv Gastroenterol2012;2:54. CrossRef

68. Garcia‐TsaoG, BoschJ. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med2010;362:823. CrossRef

69. MerkelC, MarinR, AngeliP, et al.A placebo‐controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology2004;127:476. CrossRef

70. de FranchisR. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol2005;43:167. CrossRef

71. PascalJP, CalesP. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med1987;317:856. CrossRef

72. PoynardT, CalesP, PastaL, et al.Beta‐adrenergic‐antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco‐Italian Multicenter Study Group. N Engl J Med1991;324:1532. CrossRef

73. D'AmicoG, PagliaroL, BoschJ. Pharmacological treatment of portal hypertension: an evidence‐based approach. Semin Liver Dis1999;19:475. CrossRef

74. D'AmicoG, PagliaroL, BoschJ. The treatment of portal hypertension: a meta‐analytic review. Hepatology1995;22:332.

75. HayesPC, DavisJM, LewisJA, BouchierIAD. Meta‐analysis of value of propranolol in prevention of variceal haemorrhage. Lancet1990;336:153. CrossRef

76. ImperialeTF, ChalasaniN. A meta‐analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology2001;33:802. CrossRef

77. FunakoshiN, DunyY, ValatsJC, et al.Meta‐analysis: beta‐blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol2012;11:369.

78. GluudLL, KlingenbergS, NikolovaD, GluudC. Banding ligation versus beta‐blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol2007;102:2842; quiz 2841, 2849. CrossRef

79. KhurooMS, KhurooNS, FarahatKL, et al.Meta‐analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther2005;21:347. CrossRef

80. Garcia‐PaganJC, BoschJ. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol2005;2:526. CrossRef

81. ShaheenNJ, StuartE, SchmitzSM, et al.Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology2005;41:588. CrossRef

82. AbraldesJG, TarantinoI, TurnesJ, et al.Hemodynamic response to pharmacological treatment of portal hypertension and long‐term prognosis of cirrhosis. Hepatology2003;37:902. CrossRef

83. VillanuevaC, AracilC, ColomoA, et al.Acute hemodynamic response to beta‐blockers and prediction of long‐term outcome in primary prophylaxis of variceal bleeding. Gastroenterology2009;137:119. CrossRef

84. AbraczinskasDR, OokuboR, GraceND, et al.Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?Hepatology2001;34:1096. CrossRef

85. ReibergerT, UlbrichG, FerlitschA, et al.Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non‐response to propranolol. Gut2012;62:1634. CrossRef

86. MerkelC, BolognesiM, SacerdotiD, et al.The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology2000;32:930. CrossRef

87. GraceND. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know. Am J Gastroenterol2000;95:1862. CrossRef

88. Garcia‐PaganJC, VillanuevaC, VilaMC, et al.Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta‐blockers. Gastroenterology2001;121:908. CrossRef

89. AngelicoM, CarliL, PiatC, et al.Effects of isosorbide‐5‐mononitrate compared with propranolol on first bleeding and long‐term survival in cirrhosis. Gastroenterology1997;113:1632. CrossRef

90. MerkelC, MarinR, EnzoE, et al.Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo‐Triveneto per L'ipertensione portale (GTIP). Lancet1996;348:1677. CrossRef

91. MerkelC, MarinR, SacerdotiD, et al. Long‐term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology2000;31:324. CrossRef

92. Garcia‐PaganJC, MorillasR, BañaresR, et al.Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: a double‐blind RCT. Hepatology2003;37:1260. CrossRef

93. SarinSK, WadhawanM, AgarwalSR, et al.Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol2005;100:797. CrossRef

94. BoyerTD, HaskalZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology2005;41:386. CrossRef

95. PagliaroL, D'AmicoG, SorensonTI, et al.Prevention of first bleeding in cirrhosis. A meta‐analysis of randomized trials of nonsurgical treatment. Ann Intern Med1992;117:59. CrossRef

96. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single‐blind, multicenter clinical trial. N Engl J Med1991;324:1779. CrossRef

97. MishraSR, SharmaBC, KumarA, SarinSK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta‐blockers: a randomized controlled trial. J Hepatol2011;54:1161. CrossRef

98. BoschJ, AbraldesJG, BerzigottiA, Garcia‐PaganJC. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis2008;28:3. CrossRef

99. KravetzD, SikulerE, GroszmannRJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology1986;90:1232.

100. CastanedaB, MoralesJ, LionettiR, et al.Effects of blood volume restitution following a portal hypertensive‐related bleeding in anesthetized cirrhotic rats. Hepatology2001;33:821. CrossRef

101. BoschJ, ThabutD, AlbillosA, et al.Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology2008;47:1604. CrossRef

102. BernardB, CadranelJF, VallaD, et al.Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology1995;108:1828. CrossRef

103. GoulisJ, ArmonisA, PatchD, et al.Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology1998;27:1207. CrossRef

104. BernardB, GrangéJD, KhacEN, et al.Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta‐analysis. Hepatology1999;29:1655. CrossRef

105. HouMC, LinHC, LiuTT, et al.Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology2004;39:746. CrossRef

106. RimolaA, García‐TsaoG, NavasaM, et al.Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol2000;32:142. CrossRef

107. FernandezJ, Ruiz del ArbolL, GómezC, et al.Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology2006;131:1049; quiz 1285. CrossRef

108. WellsM, ChandeN, AdamsP, et al.Meta‐analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther2012;35:1267. CrossRef

109. D'AmicoG, PagliaroL, PietrosiG, TarantinoI. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev2010;(3):CD002233.

110. LoGH, ChenWC, WangHM, et al.Low‐dose terlipressin plus banding ligation versus low‐dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices. Gut2009;58:1275. CrossRef

111. BanaresR, AlbillosA, RinconD, et al.Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta‐analysis. Hepatology2002;35:609. CrossRef

112. D'AmicoG, TrainaM, VizziniG, et al.Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital. J Hepatol1994;20:206. CrossRef

113. IoannouGN, DoustJ, RockeyDC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther2003;17:53. CrossRef

114. LevacherS, LetoumelinP, PateronD, et al.Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet1995;346:865. CrossRef

115. EscorsellA, Ruiz del ArbolL, PlanasR, et al.Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology2000;32:471. CrossRef

116. KravetzD, BoschJ, ArderiuMT, et al.Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol1988;254:G322.

117. GotzschePC, HrobjartssonA. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev2008;(3):CD000193.

118. CorleyDA, CelloJP, AdkissonW, et al.Octreotide for acute esophageal variceal bleeding: a meta‐analysis. Gastroenterology2001;120:946. CrossRef

119. FeuF, Ruiz del ArbolL, BañaresR, et al.Double‐blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology1996;111:1291. CrossRef

120. ImperialeTF, TeranJC, McCulloughAJ. A meta‐analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology1995;109:1289. CrossRef

121. VillanuevaC, OrtizJ, MinanaJ, et al.Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology2001;121:110. CrossRef

122. MoitinhoE, PlanasR, BanaresR, et al.Variceal Bleeding StudyGroup. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol2001;35:712. CrossRef

123. EscorsellA, BandiJC, AndreuV, et al.Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology2001;120:161. CrossRef

124. CalesP, MasliahC, BernardB, et al.Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med2001;344:23. CrossRef

125. de FranchisR. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol2010;53:762. CrossRef

126. StiegmannGV, GoffJS, Michaletz‐OnodyPA, et al.Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med1992;326:1527. CrossRef

127. WestabyD, WilliamsR. Status of sclerotherapy for variceal bleeding in 1990. Am J Surg1990;160:32. CrossRef

128. LaineL, CookD. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta‐analysis. Ann Intern Med1995;123:280. CrossRef

129. LoGH, LaiKH, ChengJS, et al.Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology1997;25:1101. CrossRef

130. MoitinhoE, EscorsellA, BandiJC, et al.Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology1999;117:626. CrossRef

131. Ben‐AriZ, CardinF, McCormickAP, et al.A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol1999;31:443. CrossRef

132. D'AmicoG, De FranchisR. Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators. Hepatology2003;38:599.

133. AvgerinosA, ArmonisA. Balloon tamponade technique and efficacy in variceal haemorrhage. Scand J Gastroenterol Suppl1994;207:11. CrossRef

134. HubmannR, BodlajG, CzompoM, et al.The use of self‐expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy2006;38:896. CrossRef

135. FierzFC, KistlerW, StenzV, GublerC. Treatment of esophageal variceal hemorrhage with self‐expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol2013;7:97. CrossRef

136. ZakariaMS, HamzaIM, MoheyMA, HubamnnRG. The first Egyptian experience using new self‐expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol2013;19:177. CrossRef

137. VangeliM, PatchD, BurroughsAK. Salvage tips for uncontrolled variceal bleeding. J Hepatol2002;37:703. CrossRef

138. AzoulayD, CastaingD, MajnoP, et al.Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol2001;35:590. CrossRef

139. OrloffMJ, OrloffMS, OrloffSL, et al.Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg1995;180:257.

140. HendersonJM, BoyerTD, KutnerMH, et al.Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology2006;130:1643. CrossRef

141. Garcia‐PaganJC, CacaK, BureauC, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med2010;362:2370. CrossRef

142. BoyerTD, HaskalZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology2010;51:306. CrossRef

143. LangerB, TaylorBR, MackenzieDR, et al.Further report of a prospective randomized trial comparing distal splenorenal shunt with end‐to‐side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology1985;88:424.

144. Garcia‐PaganJC, BarrufetM, CardenasA, EscorsellA. Management of gastric varices. Clin Gastroenterol Hepatol2013;12:919. CrossRef

145. WangYM, ChengLF, LiN, et al.Study of glue extrusion after endoscopic N‐butyl‐2‐cyanoacrylate injection on gastric variceal bleeding. World J Gastroenterol2009;15:4945. CrossRef

146. DhimanRK, ChawlaY, TanejaS, et al.Endoscopic sclerotherapy of gastric variceal bleeding with N‐butyl‐2‐cyanoacrylate. J Clin Gastroenterol2002;35:222. CrossRef

147. GreenwaldBD, CaldwellSH, HespenheideEE, et al.N‐2‐butyl‐cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol2003;98:1982. CrossRef

148. KindR, GuglielmiA, RodellaL, et al.Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy2000;32:512. CrossRef

149. KangEJ, JeongSW, JangJY, et al.Long‐term result of endoscopic Histoacryl (N‐butyl‐2‐cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol2011;17:1494. CrossRef

150. SarinSK, JainAK, JainM, GuptaR. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol2002;97:1010. CrossRef

151. OhoK, IwaoT, SuminoM, et al.Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy1995;27:349. CrossRef

152. TanPC, HouMC, LinHC, et al.A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N‐butyl‐2‐cyanoacrylate injection versus band ligation. Hepatology2006;43:690. CrossRef

153. LoGH, LaiKH, ChengJS, et al.A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology2001;33:1060. CrossRef

154. TanYM, GohKL, KamarulzamanA, et al.Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc2002;55:276. CrossRef

155. TurlerA, WolffM, DorlarsD, HirnerA. Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate. Gastrointest Endosc2001;53:228. CrossRef

156. ChengLF, WangZQ, LiCZ, et al.Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol2010;8:760. CrossRef

157. CaldwellSH, HespenheideEE, GreenwaldBD, et al.Enbucrilate for gastric varices: extended experience in 92 patients. Aliment Pharmacol Ther2007;26:49. CrossRef

158. JooHS, JangJY, EunSH, et al.[Long‐term results of endoscopic histoacryl (N‐butyl‐2‐cyanoacrylate) injection for treatment of gastric varices–a 10‐year experience]. Korean J Gastroenterol2007;49:320.

159. SeewaldS, AngTL, ImazuH, et al.A standardized injection technique and regimen ensures success and safety of N‐butyl‐2‐cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc2008;68:447. CrossRef

160. BinmoellerKF, WeilertF, ShahJN, KimJ. EUS‐guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos). Gastrointest Endosc2011;74:1019. CrossRef

161. RameshJ, LimdiJK, SharmaV, MakinAJ. The use of thrombin injections in the management of bleeding gastric varices: a single‐center experience. Gastrointest Endosc2008;68:877. CrossRef

162. HeneghanMA, ByrneA, HarrisonPM. An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest Endosc2002;56:422. CrossRef

163. YangWL, TripathiD, TherapondosG, et al.Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol2002;97:1381. CrossRef

164. WilliamsSG, PetersRA, WestabyD. Thrombin–an effective treatment for gastric variceal haemorrhage. Gut1994;35:1287. CrossRef

165. ChenYI, BarkunAN, SoulellisC, et al.Use of the endoscopically applied hemostatic powder TC‐325 in cancer‐related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc2012;75:1278. CrossRef

166. HolsterIL, KuipersEJ, TjwaET. Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy2013;45:63. CrossRef

167. SungJJ, LuoD, WuJC, et al.Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy2011;43:291. CrossRef

168. StanleyAJ, SmithLA, MorrisAJ. Use of hemostatic powder (Hemospray) in the management of refractory gastric variceal hemorrhage. Endoscopy2013;45(Suppl 2 UCTN):E86. CrossRef

169. IbrahimM, El‐MikkawyA, MostafaI, DevièreJ. Endoscopic treatment of acute variceal hemorrhage by using hemostatic powder TC‐325: a prospective pilot study. Gastrointest Endosc2013;78:769. CrossRef

170. ChauTN, PatchD, ChanYW, et al.Salvage transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology1998;114:981. CrossRef

171. BarangeK, PeronJM, ImaniK, et al.Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology1999;30:1139. CrossRef

172. ReesCJ, NylanderDL, ThompsonNP, et al.Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment?Liver2000;20:253. CrossRef

173. StanleyAJ, JalanR, IrelandHM, et al.A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther1997;11:171. CrossRef

174. FeuF, Garcia‐PaganJC, BoschJ, et al.Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet1995;346:1056. CrossRef

175. de FranchisR, PrimignaniM. Endoscopic treatments for portal hypertension. Semin Liver Dis1999;19:439. CrossRef

176. VillanuevaC, MiñanaJ, OrtizJ, et al.Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med2001;345:647. CrossRef

177. PatchD, SabinCA, GoulisJ, et al.A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology2002;123:1013. CrossRef

178. LoGH, ChenWC, ChenMH, et al.Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology2002;123:728. CrossRef

179. RomeroG, KravetzD, ArgonzJ, et al.Comparative study between nadolol and 5‐isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther2006;24:601. CrossRef

180. LoGH, ChenWC, LinCK, et al.Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology2008;48:580. CrossRef

181. LoGH, LaiKH, ChengJS, et al.Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology2000;32:461. CrossRef

182. de la PenaJ, BrulletE, Sanchez‐HernándezE, et al.Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology2005;41:572. CrossRef

183. RavipatiM, KatragaddaS, SwaminathanPD, et al.Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta‐analysis of randomized, controlled trials. Gastrointest Endosc2009;70:658. CrossRef

184. ThieleM, KragA, RohdeU, GluudLL. Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther2012;35:1155. CrossRef

185. ZhengM, ChenY, BaiJ, et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta‐analysis update. J Clin Gastroenterol2008;42:507. CrossRef

186. EscorsellA, BañaresR, García‐PagánJC, et al.TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology2002;35:385. CrossRef

187. D'AmicoG, Garcia‐TsaoG, PagliaroL. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol2006;44:217. CrossRef

188. WuCY, YehHZ, ChenGH. Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis. J Clin Gastroenterol2002;35:127. CrossRef

189. MishraSR, Chander SharmaB, KumarA, SarinSK. Endoscopic cyanoacrylate injection versus beta‐blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut2010;59:729. CrossRef

190. HungHH, ChangCJ, HouMC, et al.Efficacy of non‐selective beta‐blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol2012;56:1025. CrossRef

191. LoGH, LiangHL, ChenWC, et al.A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy2007;39:679. CrossRef

192. ProcacciniNJ, Al‐OsaimiAM, NorthupP, et al.Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single‐center U.S. analysis. Gastrointest Endosc2009;70:881. CrossRef

193. KanagawaH, MimaS, KouyamaH, et al.Treatment of gastric fundal varices by balloon‐occluded retrograde transvenous obliteration. J Gastroenterol Hepatol1996;11:51. CrossRef

194. IraniS, KowdleyK, KozarekR. Gastric varices: an updated review of management. J Clin Gastroenterol2011;45:133. CrossRef

195. ChoiYH, YoonCJ, ParkJH, et al.Balloon‐occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol2003;4:109. CrossRef

196. HongCH, KimHJ, ParkJH, et al.Treatment of patients with gastric variceal hemorrhage: endoscopic N‐butyl‐2‐cyanoacrylate injection versus balloon‐occluded retrograde transvenous obliteration. J Gastroenterol Hepatol2009;24:372. CrossRef

197. ZamanA. Portal hypertension‐related bleeding: management of difficult cases. Clin Liver Dis2006;10:353, ix. CrossRef

198. CubillasR, RockeyDC. Portal hypertensive gastropathy: a review. Liver Int2010;30:1094. CrossRef

199. SpinaGP, ArcidiaconoR, BoschJ, et al.Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol1994;21:461. CrossRef

200. RipollC, Garcia‐TsaoG. Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis2010;14:281. CrossRef

201. RipollC, Garcia‐TsaoG. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis2011;43:345. CrossRef

202. BieckerE. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol2013;19:5035. CrossRef

203. PrimignaniM, CarpinelliL, PreatoniP, et al.Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology2000;119:181. CrossRef

204. ZhouY, QiaoL, WuJ, et al.Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol2002;17:973. CrossRef

205. BruhaR, MarecekZ, SpicakJ, et al.Double‐blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology2002;49:1161.

206. Perez‐AyusoRM, PiquéJM, BoschJ, et al.Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet1991;337:1431. CrossRef

207. KamathPS, LacerdaM, AhlquistDA, et al.Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology2000;118:905. CrossRef

208. MezawaS, HommaH, OhtaH, et al.Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol2001;96:1155. CrossRef

209. KalafateliM, TriantosCK, NikolopoulouV, BurroughsA. Non‐variceal gastrointestinal bleeding in patients with liver cirrhosis: a review. Dig Dis Sci2012;57:2743. CrossRef

210. BhasinDK, SharmaBC, SriramPV, et al.Endoscopic management of bleeding ectopic varices with histoacryl. HPB Surg1999;11:171. CrossRef

211. WuCS, ChenCM, ChangKY. Endoscopic injection sclerotherapy of bleeding duodenal varices. J Gastroenterol Hepatol1995;10:481. CrossRef

212. BoschA, MarsanoL, VarilekGW. Successful obliteration of duodenal varices after endoscopic ligation. Dig Dis Sci2003;48:1809. CrossRef

213. ShibataD, BrophyDP, GordonFD, et al.Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension. Dis Colon Rectum1999;42:1581. CrossRef